Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
6(27%)
Results Posted
63%(5 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
5
23%
Ph not_applicable
5
23%
Ph phase_1
3
14%
Ph phase_3
3
14%
Ph phase_4
4
18%

Phase Distribution

3

Early Stage

5

Mid Stage

7

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
3(15.0%)
Phase 2Efficacy & side effects
5(25.0%)
Phase 3Large-scale testing
3(15.0%)
Phase 4Post-market surveillance
4(20.0%)
N/ANon-phased studies
5(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

6

trials recruiting

Total Trials

22

all time

Status Distribution
Active(6)
Completed(8)
Terminated(1)
Other(7)

Detailed Status

Completed8
unknown7
Recruiting4
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
6
Success Rate
88.9%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (15.0%)
Phase 25 (25.0%)
Phase 33 (15.0%)
Phase 44 (20.0%)
N/A5 (25.0%)

Trials by Status

completed836%
recruiting418%
active_not_recruiting29%
unknown732%
terminated15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07190196Phase 3

A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease

Recruiting
NCT06246513Phase 3

A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4

Active Not Recruiting
NCT02997605Phase 4

Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients

Completed
NCT06047171Phase 2

Rescue of Nephrons With ALE.F02 (RENAL-F02)

Recruiting
NCT06788158Phase 1

Clinical Effects of Incobotulinum Toxin vs Corticosteroid in Plantar Fascitis

Active Not Recruiting
NCT06654596Not Applicable

Efficacy and Safety of Telitacicept in IgAN

Recruiting
NCT04972968Phase 2

A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154

Terminated
NCT05916781Phase 4

Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus

Recruiting
NCT03821714Not Applicable

Effects of Glucocorticoid Combined With Vitamin C and Vitamin B1 on Microcirculation in Severe Septic Shock

Completed
NCT05525065

Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs)

Unknown
NCT05969522Phase 4

Stratified Therapy on Pediatric AAGN

Unknown
NCT05855395Not Applicable

The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19

Unknown
NCT05764304Phase 3

Sinomenine Versus Glucocorticoid for Knee OA

Unknown
NCT05606107Phase 4

To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks

Unknown
NCT04499196

Glucocorticoids and Pulmonary Hypertension

Unknown
NCT01576588Phase 2

Rituximab in Pretreated Elderly or Unfit B-CLL Patients

Completed
NCT02182492Not Applicable

Efficacy of Macrolide and Glucocorticoid in the Treatment of Chronic Rhinosinusitis After Endoscopic Sinus Surgery

Completed
NCT00805207Not Applicable

Sex Steroids, Sleep, and Metabolic Dysfunction in Women

Completed
NCT02543073Phase 1

MSC for Treatment of Interstitial Lung Disease After Allo-HSCT

Unknown
NCT00474383Phase 2

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22